HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Types I and III procollagen extension peptides in serum respond to fracture in humans.

Abstract
Markers of types I and III collagen turnover were measured in serial blood samples in 16 patients with a Colles' fracture. The collagen markers were the carboxy-terminal extension peptide of type I procollagen (PICP) and the amino-terminal extension peptide of type III procollagen (PIIINP). Significant increases were found of PIIINP within 1 week and of PICP within 2 weeks. This sequential appearance of PIIINP and PICP was found to be in agreement with the appearance of types III and I collagen during early fracture healing as demonstrated in previous animal experimental studies. PICP had levelled off after 9 months, whereas PIIINP remained elevated. Osteocalcin, a serum marker of osteoblast activity, increased within 1 week and levelled off after 9 months. Correlations between the change in osteocalcin and those in PICP and PIIINP, respectively, were weak. These new biochemical markers may prove relevant as non-invasive markers of normal and pathological fracture healing in humans.
AuthorsS Joerring, L T Jensen, G R Andersen, J S Johansen
JournalArchives of orthopaedic and trauma surgery (Arch Orthop Trauma Surg) Vol. 111 Issue 5 Pg. 265-7 ( 1992) ISSN: 0936-8051 [Print] Germany
PMID1389778 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Peptide Fragments
  • Procollagen
  • procollagen Type III-N-terminal peptide
  • procollagen type I carboxy terminal peptide
  • Osteocalcin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Colles' Fracture (blood, therapy)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Osteocalcin (blood)
  • Peptide Fragments (blood)
  • Procollagen (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: